Eduardo Monguilhott Dalmarco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eduardo Monguilhott Dalmarco has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Eduarda Talita Bramorski Mohr
13 shared publications- Ianka Cristina Celuppi
Universidade Federal de Santa Catarina, Brazil
10 shared publications - Raul Sidnei Wazlawick
Laboratório Bridge, Brasil; UFSC, Brasil
10 shared publications - Eduarda Talita Bramorski Mohr
Laboratório Bridge, Brasil; Universidade Federal de Santa Catarina (UFSC), Brasil
9 shared publications Mariano Felisberto
9 shared publications- Jades Fernando Hammes
Bridge Laboratory, Federal University of Santa Catarina, Florianópolis, Brazil
8 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (11) , 7321-7322
Correction: The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPAR-γ and M2 macrophage subpopulations
- 12 October 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (11) , 7321-7322
Open AccessCorrection: The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPAR-γ and M2 macrophage subpopulations
- Open Access
- 25 September 2026
- Published by Universidad Nacional de La Plata in Revista Iberoamericana de Tecnología en Educación y Educación en Tecnología
- No. 44
Aplicativo Jornada do Estudante (app): Uma estratégia do Ministério da Educação (MEC) para transformar o ecossistema digital da educação no Brasil
The Student Journey (JE) was designed to offer services capable of transforming the digital educational ecosystem in Brazil. This article presents the technological strategy developed and its benefits for Brazilian students, academic institutions, and public administrators nationwide. Throughout the article, we cover the functionalities of JE in operation, such as authentication by Gov.br, proof of student affiliation, academic diploma, push notification resources, academic progress, development centered on the user experience, and the monitoring tool of the Pé-de-Meia program, a federal government aid program for high school students. The discussions seek to disseminate knowledge about JE so that Brazil's administrators and educational professionals can plan the implementation of the strategy in the academic context to reduce costs, such as human resources, system development, and printed material
- 25 September 2026
- Published by Universidad Nacional de La Plata in Revista Iberoamericana de Tecnología en Educación y Educación en Tecnología
- No. 44
Open AccessAplicativo Jornada do Estudante (app): Uma estratégia do Ministério da Educação (MEC) para transformar o ecossistema digital da educação no Brasil
The Student Journey (JE) was designed to offer services capable of transforming the digital educational ecosystem in Brazil. This article presents the technological strategy developed and its benefits for Brazilian students, academic institutions, and public administrators nationwide. Throughout the article, we cover the functionalities of JE in operation, such as authentication by Gov.br, proof of student affiliation, academic diploma, push notification resources, academic progress, development centered on the user experience, and the monitoring tool of the Pé-de-Meia program, a federal government aid program for high school students. The discussions seek to disseminate knowledge about JE so that Brazil's administrators and educational professionals can plan the implementation of the strategy in the academic context to reduce costs, such as human resources, system development, and printed material
- Open Access
- 18 June 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 219, 106548
Fast healthcare interoperability resources (FHIR) implementation guide creation process: scoping review
- 18 June 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 219, 106548
Open AccessFast healthcare interoperability resources (FHIR) implementation guide creation process: scoping review
- Open Access
- 3 June 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 218, 106516
Optimising screening efficiency in evidence synthesis on health Technology: A simulation study using ASReview
- 3 June 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 218, 106516
Open AccessOptimising screening efficiency in evidence synthesis on health Technology: A simulation study using ASReview
- Open Access
- 20 May 2026
- Published by Sociedade Brasileira de Informática em Saúde in Journal of Health Informatics
- Vol. 18
An evaluation framework for information systems from the users’ perspective: a scoping review
This scoping review aims to synthesize scientific literature on information systems evaluation methods from the users’ perspective, focusing on their characteristics, construction stages, and measurement properties. The search was conducted in 2024 across the following databases: ACM Digital Library, Embase, Engineering Village, ERIC, IEEE Xplore, LILACS, MEDLINE (via PubMed), Scopus, and Web of Science. The study selection process was independently carried out by two reviewers. A total of 18,837 articles were identified in the searches, and 11 were ultimately included in the review. The studies presented various evaluation frameworks specifically for health information systems, with one study also evaluating information systems from other fields. Only five studies reported the frameworks’ validation procedures, and very few provided comprehensive results of the validations or sufficiently thorough analyses. This scoping review underscores the methodological diversity in information systems evaluation models and highlights the limitations of current use. It emphasizes the need for standardized approaches to enhance comparability, transparency, and long-term system development.
- 20 May 2026
- Published by Sociedade Brasileira de Informática em Saúde in Journal of Health Informatics
- Vol. 18
Open AccessAn evaluation framework for information systems from the users’ perspective: a scoping review
This scoping review aims to synthesize scientific literature on information systems evaluation methods from the users’ perspective, focusing on their characteristics, construction stages, and measurement properties. The search was conducted in 2024 across the following databases: ACM Digital Library, Embase, Engineering Village, ERIC, IEEE Xplore, LILACS, MEDLINE (via PubMed), Scopus, and Web of Science. The study selection process was independently carried out by two reviewers. A total of 18,837 articles were identified in the searches, and 11 were ultimately included in the review. The studies presented various evaluation frameworks specifically for health information systems, with one study also evaluating information systems from other fields. Only five studies reported the frameworks’ validation procedures, and very few provided comprehensive results of the validations or sufficiently thorough analyses. This scoping review underscores the methodological diversity in information systems evaluation models and highlights the limitations of current use. It emphasizes the need for standardized approaches to enhance comparability, transparency, and long-term system development.
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 9 (3) , ooag100
Use and characteristics of free/libre and open source electronic health records: an overview of reviews
Objective: To synthesize and consolidate the existing evidence on the use and characteristics of Free/Libre and Open Source Software (FLOSS)-based electronic health records (EHRs) in global healthcare settings. Materials and Methods: We conducted an overview of reviews, systematically searching 14 information sources using a peer-reviewed strategy. Pairs of reviewers independently and in duplicate screened studies, extracted predefined data items, and assessed methodological quality. Findings were synthesized thematically and categorized by use and system characteristics. Results: Nine systematic reviews (2012-2024) met the inclusion criteria. Methodological quality was generally low. We identified 26 themes related to use and 19 related to system characteristics. FLOSS-based EHRs were predominantly implemented in low- and middle-income countries, driven by cost advantages, adaptability, and community support. Reported challenges included organizational barriers, uncertainties about the capacity of volunteer-led development communities, limited comparative evidence with proprietary systems, and concerns over set-up, customization and training costs. System characteristics varied, especially regarding interoperability, security, and governance. Discussion: The implementation of FLOSS-based EHRs appears to be influenced more by institutional and organizational factors than by technical features. Their adaptability supports use in resource-limited settings, but persistent challenges may raise concerns about long-term sustainability. Conclusion: To realize the potential of FLOSS-based EHRs, stakeholders must strengthen institutional readiness and governance structures, while the research community must improve the methodological quality of supporting evidence.
- 5 May 2026
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 9 (3) , ooag100
Open AccessUse and characteristics of free/libre and open source electronic health records: an overview of reviews
Objective: To synthesize and consolidate the existing evidence on the use and characteristics of Free/Libre and Open Source Software (FLOSS)-based electronic health records (EHRs) in global healthcare settings. Materials and Methods: We conducted an overview of reviews, systematically searching 14 information sources using a peer-reviewed strategy. Pairs of reviewers independently and in duplicate screened studies, extracted predefined data items, and assessed methodological quality. Findings were synthesized thematically and categorized by use and system characteristics. Results: Nine systematic reviews (2012-2024) met the inclusion criteria. Methodological quality was generally low. We identified 26 themes related to use and 19 related to system characteristics. FLOSS-based EHRs were predominantly implemented in low- and middle-income countries, driven by cost advantages, adaptability, and community support. Reported challenges included organizational barriers, uncertainties about the capacity of volunteer-led development communities, limited comparative evidence with proprietary systems, and concerns over set-up, customization and training costs. System characteristics varied, especially regarding interoperability, security, and governance. Discussion: The implementation of FLOSS-based EHRs appears to be influenced more by institutional and organizational factors than by technical features. Their adaptability supports use in resource-limited settings, but persistent challenges may raise concerns about long-term sustainability. Conclusion: To realize the potential of FLOSS-based EHRs, stakeholders must strengthen institutional readiness and governance structures, while the research community must improve the methodological quality of supporting evidence.
- 4 May 2026
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 48 (3) , 469-478
The anti-inflammatory activity and toxicological safety of synthetic chalcone derivatives in preclinical trials
Inflammation is an essential physiological defense mechanism that aims to maintain homeostasis. However, it can lead to chronic or autoimmune diseases. The chalcones structural flexibility represents a promising class for developing new drugs and exhibits diverse activities, including anti-inflammatory effects. To evaluate the cell viability and anti-inflammatory potential of 23 chalcone derivative compounds by measuring nitric oxide metabolites in a model of lipopolysaccharide-stimulated J774A.1 cells. After using the acute lung injury model in mice, the acute oral toxicity of compounds with favorable in vitro profiles was determined according to guideline 423 of the Organization for Economic Cooperation and Development. Of the compounds tested in J774A.1 cells (n = 23) and seventeen showed acceptable results and were subjected to nitric oxide inhibition after lipopolysaccharide stimulation; two (RX10.2 and RX10.4) compounds showed significant inhibition under this inflammatory parameter. The compounds were then tested in vivo. RX10.4 failed to reproduce the in vitro anti-inflammatory effect. Nevertheless, RX10.2 demonstrated exciting performance, reducing the leukocyte migration on the bronchoalveolar lavage by limiting neutrophil influx and exudation levels. The compound also significantly reduced nitric oxide levels and myeloperoxidase activity. Lastly, RX10.2 did not show signs of acute oral toxicity. RX10.2 showed important anti-inflammatory activity in vitro and in vivo without acute toxicity. This finding justifies further investigation, as it proved to be a promising prototype for developing new anti-inflammatory drugs.
- 4 May 2026
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 48 (3) , 469-478
The anti-inflammatory activity and toxicological safety of synthetic chalcone derivatives in preclinical trials
Inflammation is an essential physiological defense mechanism that aims to maintain homeostasis. However, it can lead to chronic or autoimmune diseases. The chalcones structural flexibility represents a promising class for developing new drugs and exhibits diverse activities, including anti-inflammatory effects. To evaluate the cell viability and anti-inflammatory potential of 23 chalcone derivative compounds by measuring nitric oxide metabolites in a model of lipopolysaccharide-stimulated J774A.1 cells. After using the acute lung injury model in mice, the acute oral toxicity of compounds with favorable in vitro profiles was determined according to guideline 423 of the Organization for Economic Cooperation and Development. Of the compounds tested in J774A.1 cells (n = 23) and seventeen showed acceptable results and were subjected to nitric oxide inhibition after lipopolysaccharide stimulation; two (RX10.2 and RX10.4) compounds showed significant inhibition under this inflammatory parameter. The compounds were then tested in vivo. RX10.4 failed to reproduce the in vitro anti-inflammatory effect. Nevertheless, RX10.2 demonstrated exciting performance, reducing the leukocyte migration on the bronchoalveolar lavage by limiting neutrophil influx and exudation levels. The compound also significantly reduced nitric oxide levels and myeloperoxidase activity. Lastly, RX10.2 did not show signs of acute oral toxicity. RX10.2 showed important anti-inflammatory activity in vitro and in vivo without acute toxicity. This finding justifies further investigation, as it proved to be a promising prototype for developing new anti-inflammatory drugs.
- Open Access
- 22 April 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (6) , 3817-3833
The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPARγ and M2 macrophage subpopulations
Thiazolidine derivatives exert anti-inflammatory effects by inhibiting the NF-κB pathway and promoting macrophage polarization toward the anti-inflammatory M2 phenotype, partially through PPARγ activation. Our previous work identified thiazolidine derivative 13 [methyl 2-(benzoylimino)-3-methyl-4-(4-nitrobenzyl)-1,3-thiazolidine-4-carboxylate] as a potent immunomodulator that reduces pro-inflammatory mediators and enhances anti-inflammatory markers. However, its direct interaction with PPARγ remains unclear. This study aims to evaluate whether thiazolidine 13 activates PPARγ and contributes to M2 macrophage polarization using LPS-stimulated RAW 264.7 cells, cell transactivation assay and reporter gene (Hella cells), LPS-stimulated THP-1 cells, and molecular docking analysis. Compound 13 reduced NO₂⁻ production, CD80 expression, and pro-inflammatory cytokines while increasing IL-10, TGF-β, and CD206 in LPS-stimulated RAW 264.7 macrophages. Compound 13 also inhibited NO production in LPS-stimulated THP-1 cells. These effects were only partially reversed by PPARγ antagonists, suggesting additional PPARγ-independent mechanisms, while the induction of CD206 was closely linked to partial PPARγ activation. Docking studies supported this profile, showing that the (S) enantiomer of thiazolidine 13 adopts a binding mode typical of partial PPARγ agonists and exhibits a higher predicted affinity than the (R) enantiomer. Compound 13 acts as a partial PPARγ modulator capable of shifting macrophages from a pro-inflammatory toward an anti-inflammatory phenotype (M2-like). This dual action relies on the inhibition of NF-κB signaling and partial PPARγ activation. The predominance of the M2-like subpopulation, underscores its role in resolving inflammation and promoting tissue repair. Graphical abstract The alternative text for this image may have been generated using AI.
- 22 April 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (6) , 3817-3833
Open AccessThe anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPARγ and M2 macrophage subpopulations
Thiazolidine derivatives exert anti-inflammatory effects by inhibiting the NF-κB pathway and promoting macrophage polarization toward the anti-inflammatory M2 phenotype, partially through PPARγ activation. Our previous work identified thiazolidine derivative 13 [methyl 2-(benzoylimino)-3-methyl-4-(4-nitrobenzyl)-1,3-thiazolidine-4-carboxylate] as a potent immunomodulator that reduces pro-inflammatory mediators and enhances anti-inflammatory markers. However, its direct interaction with PPARγ remains unclear. This study aims to evaluate whether thiazolidine 13 activates PPARγ and contributes to M2 macrophage polarization using LPS-stimulated RAW 264.7 cells, cell transactivation assay and reporter gene (Hella cells), LPS-stimulated THP-1 cells, and molecular docking analysis. Compound 13 reduced NO₂⁻ production, CD80 expression, and pro-inflammatory cytokines while increasing IL-10, TGF-β, and CD206 in LPS-stimulated RAW 264.7 macrophages. Compound 13 also inhibited NO production in LPS-stimulated THP-1 cells. These effects were only partially reversed by PPARγ antagonists, suggesting additional PPARγ-independent mechanisms, while the induction of CD206 was closely linked to partial PPARγ activation. Docking studies supported this profile, showing that the (S) enantiomer of thiazolidine 13 adopts a binding mode typical of partial PPARγ agonists and exhibits a higher predicted affinity than the (R) enantiomer. Compound 13 acts as a partial PPARγ modulator capable of shifting macrophages from a pro-inflammatory toward an anti-inflammatory phenotype (M2-like). This dual action relies on the inhibition of NF-κB signaling and partial PPARγ activation. The predominance of the M2-like subpopulation, underscores its role in resolving inflammation and promoting tissue repair. Graphical abstract The alternative text for this image may have been generated using AI.
- Open Access
- 26 January 2026
- Published by Springer Nature in Health and Technology
- Vol. 16 (2) , 169-207
The Brazilian telehealth systems: a scoping review
Purpose: This study sought to answer the research question “What are the characteristics of telehealth systems already implemented in Brazil?”. Methods: A comprehensive electronic search was conducted in eight databases (Embase, LILACS, PubMed/MEDLINE, Scopus, Web of Science, the ACM Digital Library, Engineering Village, and the IEEE Digital Library) on June 7, 2023. Additionally, we explored gray literature using Google Scholar and ProQuest Dissertations & Theses Global. The inclusion criteria encompassed studies detailing the characteristics of various telehealth systems implemented in Brazil, regardless of the system type, purpose, or medical conditions addressed. The methodological quality of each study was assessed using the JBI checklists. Results: The search yielded 60 relevant studies, of which 44 examined public telehealth systems, and seven focused on private systems. Regarding communication functionality, nearly half (46.7%) incorporated both synchronous and asynchronous features, and the proportions of studies investigating exclusively synchronous or asynchronous systems were fairly similar (23.3% and 16.7%, respectively). None of the studies attained complete methodological quality. Conclusion: This review successfully identified and mapped 35 telehealth systems implemented across Brazil, predominantly in Minas Gerais and Rio Grande do Sul States, and revealed that most systems were part of the public sector and offered a mix of synchronous and asynchronous communication functionalities. Future research should delve into the intricacies and specificities of Brazilian telehealth systems and develop comprehensive tools and data for their evaluation.
- 26 January 2026
- Published by Springer Nature in Health and Technology
- Vol. 16 (2) , 169-207
Open AccessThe Brazilian telehealth systems: a scoping review
Purpose: This study sought to answer the research question “What are the characteristics of telehealth systems already implemented in Brazil?”. Methods: A comprehensive electronic search was conducted in eight databases (Embase, LILACS, PubMed/MEDLINE, Scopus, Web of Science, the ACM Digital Library, Engineering Village, and the IEEE Digital Library) on June 7, 2023. Additionally, we explored gray literature using Google Scholar and ProQuest Dissertations & Theses Global. The inclusion criteria encompassed studies detailing the characteristics of various telehealth systems implemented in Brazil, regardless of the system type, purpose, or medical conditions addressed. The methodological quality of each study was assessed using the JBI checklists. Results: The search yielded 60 relevant studies, of which 44 examined public telehealth systems, and seven focused on private systems. Regarding communication functionality, nearly half (46.7%) incorporated both synchronous and asynchronous features, and the proportions of studies investigating exclusively synchronous or asynchronous systems were fairly similar (23.3% and 16.7%, respectively). None of the studies attained complete methodological quality. Conclusion: This review successfully identified and mapped 35 telehealth systems implemented across Brazil, predominantly in Minas Gerais and Rio Grande do Sul States, and revealed that most systems were part of the public sector and offered a mix of synchronous and asynchronous communication functionalities. Future research should delve into the intricacies and specificities of Brazilian telehealth systems and develop comprehensive tools and data for their evaluation.
- 25 August 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 197 (Pt A) , 110983
Mapping the evaluation of Brazil's national electronic health system for primary care (PEC e-SUS APS): a scoping review
- 25 August 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 197 (Pt A) , 110983
Mapping the evaluation of Brazil's national electronic health system for primary care (PEC e-SUS APS): a scoping review